Biotech Values

[skitahoe]

Druggie won't agree with me, but I certainly agree with him, TNFerade showed itself to be very effective with the 92 event data. I believe the effect of nearly all added patients getting endoscopic dosing of TNFerade will show a marked improvement in the 184 event data as roughly 250 of the nearly 300 in the trials who received TNFerade will have gotten it endoscopically.

I doubt Stat Sig will be reached at the penalized level required at 184 events, but it should be at roughly the level required at the end of the trial, though improvement can certainly be expected then as the longest living patients will end up in that data.

http://investorshub.advfn.com/uimage/uploads/2010/1/29/frndgpiratefinalnew.jpg

Gary